1. Sweden Stocks

  2. •

    Healthcare

  3. •

    Medical - Instruments & Supplies
AddLife AB (publ)

AddLife AB (publ)

ADDLF
AddLife AB (publ)US flagOther OTC
15.75
USD
+7.81
- -
1.85BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
9.94
10.78
13.64
19.83
22.83
24.7
31.32
47.03
66.93
74.59
79.48
84.41
85.69
85.69
Basic EPS, GAAP
0.81
0.86
1.04
0.99
1.18
1.29
1.27
4.62
6.02
3.94
1.56
2.07
4.6
2.77
Free Cash Flow per Basic Share
1.2
0.86
1.34
0.96
1.62
1.28
2.83
7.65
7.26
5.15
3.82
6.55
9.09
9.54
Dividend per Share
1.01
1.06
1.03
3.74
0.36
0.53
0.56
0.5
1.53
2
1.2
0.5
0.75
0.75
Book Value per Share
3.29
3
3.4
1.13
1.99
2.67
2.71
7.11
13.47
15.18
15.44
16.92
20.83
- -
Tangible Book Value per Share
0.9
0.76
0.91
-4.93
-3.96
-5.31
-2.56
-1
-24.28
-28.49
-24.66
-21.59
-16.41
-20.46
Basic Weighted Avg Shares
91
91
77
79
102
100
111
112
119
122
122
122
122
122
Sales/Revenue/Turnover
906
984
1,057
1,562
2,333
2,482
3,479
5,273
7,993
9,084
9,685
10,286
10,442
10,442
Operating Margin (%)
10.77
10.64
10.34
6.49
6.86
6.41
5.42
10.46
11.94
7.84
4.51
6.96
7.94
7.45
Depreciation Expense
30
25
22
44
88
99
233
274
478
723
919
812
809
- -
Net Income, GAAP
74
78
80
78
120
129
141
518
719
480
190
252
560
337
Effective Tax Rate (%)
23.77
23.54
23.65
22.36
23.67
18.16
21.94
21.14
22.22
19.77
43.36
37.28
27.2
33.53
Profit Margin (%)
8.14
7.93
7.61
4.98
5.16
5.21
4.04
9.82
9
5.28
1.96
2.45
5.36
3.23
Working Capital
90
65
117
-41
-346
-477
-280
-53
-2,161
-884
-697
744
158
-278
LT Debt
25
32
- -
301
4
10
149
242
788
2,969
2,886
4,093
2,831
2,915
Total Equity
293
272
263
347
748
932
1,476
1,890
4,291
4,971
4,960
5,309
5,447
5,268
Return on Invested Capital (%)
- -
25.38
27.88
13.81
11.31
8.38
7.05
16.99
13.26
5.99
2.37
4.35
5.83
4.97
Return on Capital (%)
- -
25.04
27.67
19.14
19.29
14.61
12.8
37.57
20.78
8.61
4.71
6.12
9.76
6.43
Return on Common Equity (%)
- -
27.18
29.94
44.22
82.4
54.89
49.46
94.32
59.76
27.76
10.19
12.78
24.34
- -

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
979
1,984
2,119
LT Borrowings
3,738
- -
- -
LT Finance Leases
355
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
122
122
122
Market Capitalization
56,869
51,596
48,653

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
3,929
3,747
3,818
Cash, Cash Equivalents & STI
331
368
253
Accounts Receivable, Net
1,531
1,727
1,846
Inventories
1,724
1,652
1,719
Total Current Liabilities
3,185
3,989
4,096
Payables & Accruals
- -
- -
- -
ST Debt
979
1,984
2,119
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
41.08%
30.45%
2.6%
Free Cash Flow
44.4%
11.6%
38.85%
Net Income, GAAP
43.59%
20.01%
122.22%
Sales/Revenue/Turnover
27.49%
15.91%
1.52%
Total Cash Common Dividend
44.31%
41.89%
49.18%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,570
2,554
2,344
2,818
10,286
2025
2,702
2,578
2,733
- -
10,442
2026
2,645
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.51
0.59
0.2
0.77
2.07
2025
0.98
0.82
2.13
- -
4.6
2026
1.04
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
0.5
- -
- -
0.5
2025
- -
0.75
- -
- -
0.75
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Fredrik Dalborg
Full Time Employees
2,251
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
Brunkebergstorg 5 Stockholm Sweden 103 62
IPO Date
Nov 27, 2018
Website
add.life
Similar Companies
Carl Zeiss Meditec AG (CZMWY)
AddLife AB (publ) (ALIF-B.ST)
Meihua International Medical Technologies Co., Ltd. (MHUA)
S2Medical AB (publ) (S2M.ST)
Ship Healthcare Holdings, Inc. (3360.T)
NanoString Technologies, Inc. (NSTG)
Business
AddLife AB (publ) operates as an independent European player within the life science sector, supplying a diverse array of equipment, consumables, and reagents primarily to healthcare systems, research institutions, educational establishments, and the food and pharmaceutical industries. The company structures its operations across two distinct segments: Labtech and Medtech. The Labtech segment delivers products, comprehensive solutions, and services focused on diagnostics, biomedical research, and laboratory analysis, encompassing areas such as hematology, pathology, point-of-care diagnostics, cell biology, genetics, microbiology, molecular biology, clinical chemistry, immunology, and analytical instruments. This segment additionally offers extensive support, maintenance, consulting, and training services to its clientele. The Medtech segment is dedicated to providing medical device products for surgery, respiration, intensive care, wound care, enteral nutrition, and ear, nose, and throat procedures, alongside welfare technology, assistive devices for home care, and specialized aids for children with disabilities. AddLife has a significant presence across approximately 30 countries in Europe, including Sweden, Finland, Denmark, Norway, the United Kingdom, Ireland, Germany, Italy, Austria, Switzerland, and Spain. Recent strategic moves include the April 2025 acquisition of Edge Medical Ltd., enhancing its offerings in orthopedic surgery, and the July 2024 acquisition of BonsaiLab, which bolstered its molecular biology capabilities in the Iberian market. Founded in 1906, AddLife AB (publ) maintains its headquarters in Stockholm, Sweden.

Company News

APIChat

  • seekingalpha.com

    AddLife AB (publ) (ADDLF) Q1 2026 Earnings Call Transcript

  • seekingalpha.com

    AddLife AB (publ) (ADDLF) Q4 2025 Earnings Call Transcript